From: Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases
KRAS-wt
n = 49
KRAS-mut
n = 33
P-value
Total cohort
25/49 (51.0%)
15/33 (45.5%)
0.658
Synchronous metastases
15/26 (57.7%)
6/20 (30.0%)
0.079
Metachronous metastases
10/23 (43.5%)
9/13 (69.2%)
0.177